Both in Pharmaceuticals
USANA Health Sciences vs Larimar Therapeutics
Over the past year USNA returned −30.0% and LRMR returned −34.5%; their daily moves had a correlation of -0.04.
USNA −30.0% LRMR −34.5%Growth of $1, one year, split-adjusted
| Metric | USNA | LRMR |
|---|---|---|
| Price | $14.87 | $2.54 |
| Market cap | $274.7M | $263.9M |
| Today | +1.02% | +7.17% |
| 1 month | +0.1% | −11.2% |
| 6 months | −22.8% | −36.7% |
| Year to date | −24.2% | −33.3% |
| 1 year | −29.7% | −34.7% |
| Revenue growth (YoY) | −5.3% | — |
| Gross margin | 78.3% | — |
| Net margin | −9.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | $168.6M | $156.3M |
| Dividend yield | — | — |
| Volatility (60d) | 34.9% | 79.0% |
| Short % of float | 7.2% | 23.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).